Abstract
Undue exposure to antimicrobials has led to the acquisition and development of sophisticated bacterial resistance mechanisms, such as efflux pumps, which are able to expel or reduce the intracellular concentration of various antibiotics, making them ineffective. Therefore, inhibiting this mechanism is a promising way to minimize the phenomenon of resistance in bacteria. In this sense, the present study sought to evaluate the activity of the Carvacrol (CAR) and Thymol (THY) terpenes as possible Efflux Pump Inhibitors (EPIs), by determining the Minimum Inhibitory Concentration (MIC) and the association of these compounds in subinhibitory concentrations with the antibiotic Norfloxacin and with Ethidium Bromide (EtBr) against strains SA-1199 (wild-type) and SA-1199B (overexpresses NorA) of Staphylococcus aureus. In order to verify the interaction of the terpenes with the NorA efflux protein, an in silico molecular modeling study was carried out. The assays used to obtain the MIC of CAR and THY were performed by broth microdilution, while the Efflux Pump inhibitory test was performed by the MIC modification method of the antibiotic Norfloxacin and EtBr. docking was performed using the Molegro Virtual Docker (MVD) program. The results of the study revealed that CAR and THY have moderate bacterial activity and are capable of reducing the MIC of Norfloxacin antibiotic and EtBr in strains of S. aureus carrying the NorA efflux pump. The docking results showed that these terpenes act as possible competitive NorA inhibitors and can be investigated as adjuvants in combined therapies aimed at reducing antibiotic resistance.
Similar content being viewed by others
Data availability
The datasets generated during and/or analyzed during the current study are available from the corresponding author on reasonable request.
References
Almeida RS, Freitas PR, Araújo ACJ et al (2020) GC-MS profile and enhancement of antibiotic activity by the essential oil of Ocotea odorífera and safrole: inhibition of Staphylococcus aureus efflux pumps. Antibiotics 9:247. https://doi.org/10.3390/antibiotics9050247
Andrews JM (2001) Determination of minimum inhibitory concentrations. J Antimicrob Chemother 48:5–16. https://doi.org/10.1093/jac/48.suppl_1.5
Aron Z, Opperman TJ (2018) The hydrophobic trap—the Achilles heel of RND efflux pumps. Res Microbiol 169:393–400. https://doi.org/10.1016/j.resmic.2017.11.001
Banerjee A, Majumder P, Sanyal S et al (2014) The DNA intercalators ethidium bromide and propidium iodide also bind to core histones. FEBS Open Bio 4:251–259. https://doi.org/10.1016/j.fob.2014.02.006
Baugh S, Phillips CR, Ekanayaka AS et al (2014) Inhibition of multidrug efflux as a strategy to prevent biofilm formation. J Antimicrob Chemother 69:673–681. https://doi.org/10.1093/jac/dkt420
Ben Arfa A, Combes S, Preziosi-Belloy L et al (2006) Antimicrobial activity of carvacrol related to its chemical structure. Lett Appl Microbiol 43:149–154. https://doi.org/10.1111/j.1472-765X.2006.01938.x
Bhaskar BV, Babu TMC, Reddy NV, Rajendra W (2016) Homology modeling, molecular dynamics, and virtual screening of NorA efflux pump inhibitors of Staphylococcus aureus. Drug Des Devel Ther 10:3237–3252. https://doi.org/10.2147/DDDT.S113556
Blanco P, Hernando-Amado S, Reales-Calderon J et al (2016) Bacterial multidrug efflux pumps: much more than antibiotic resistance determinants. Microorganisms 4:14. https://doi.org/10.3390/microorganisms4010014
Boye A, Addo JK, Acheampong DO et al (2020) The hydroxyl moiety on carbon one (C1) in the monoterpene nucleus of thymol is indispensable for anti-bacterial effect of thymol. Heliyon 6:e03492. https://doi.org/10.1016/j.heliyon.2020.e03492
Buonerba F, Lepri S, Goracci L et al (2017) Improved potency of indole-based NorA efflux pump inhibitors: from serendipity toward rational design and development. J Med Chem 60:517–523. https://doi.org/10.1021/acs.jmedchem.6b01281
Cirino ICS, Menezes-Silva SMP, Silva HTD et al (2015) The essential oil from Origanum vulgare L. and its individual constituents carvacrol and thymol enhance the effect of tetracycline against Staphylococcus aureus. Chemotherapy 60:290–293. https://doi.org/10.1159/000381175
Coêlho ML, Ferreira JHL, de Siqueira Júnior JP et al (2016) Inhibition of the NorA multi-drug transporter by oxygenated monoterpenes. Microb Pathog 99:173–177. https://doi.org/10.1016/j.micpath.2016.08.026
Coutinho HDM, Costa JGM, Lima EO et al (2008) Enhancement of the antibiotic activity against a multiresistant Escherichia coli by Mentha arvensis L. and chlorpromazine. Chemotherapy 54:328–330. https://doi.org/10.1159/000151267
Coutinho HDM, Brito SMO, Leite NF et al (2015) Comparative evaluation of the modulation of antibiotic-activity against strains of escherichia coli and staphylococcus aureus. Rev Ciencias la Salud 13:345–354. https://doi.org/10.12804/revsalud13.03.2015.02
Dhifi W, Bellili S, Jazi S et al (2016) Essential oils’ chemical characterization and investigation of some biological activities: a critical review. Medicines 3:25. https://doi.org/10.3390/medicines3040025
dos Santos JFS, Tintino SR, de Freitas TS et al (2018) In vitro e in silico evaluation of the inhibition of Staphylococcus aureus efflux pumps by caffeic and gallic acid. Comp Immunol Microbiol Infect Dis 57:22–28. https://doi.org/10.1016/j.cimid.2018.03.001
El Meouche I, Dunlop MJ (2018) Heterogeneity in efflux pump expression predisposes antibiotic-resistant cells to mutation. Science (80-) 362:686–690. https://doi.org/10.1126/science.aar7981
Elshikh M, Ahmed S, Funston S et al (2016) Resazurin-based 96-well plate microdilution method for the determination of minimum inhibitory concentration of biosurfactants. Biotechnol Lett 38:1015–1019. https://doi.org/10.1007/s10529-016-2079-2
Grace D, Fetsch A (2018) Staphylococcus aureus —a foodborne pathogen. In: Staphylococcus aureus. Epidemiology, detection, characterization, prevention, and control: an overview. In: Fetsch A (ed), Staphylococcus aureus. Academic Press, Cambridge, pp 3–10. https://doi.org/10.1016/B978-0-12-809671-0.00001-2
Guilhelmelli F, Vilela N, Albuquerque P et al (2013) Antibiotic development challenges: the various mechanisms of action of antimicrobial peptides and of bacterial resistance. Front Microbiol 4:1–12. https://doi.org/10.3389/fmicb.2013.00353
Guimarães AC, Meireles LM, Lemos MF et al (2019) Antibacterial activity of terpenes and terpenoids present in essential oils. Molecules 24:2471. https://doi.org/10.3390/molecules24132471
Güvenç M, Cellat M, Gökçek İ et al (2019) Effects of thymol and carvacrol on sperm quality and oxidant/antioxidant balance in rats. Arch Physiol Biochem 125:396–403. https://doi.org/10.1080/13813455.2018.1476979
Hassanzadeh S, Ganjloo S, Pourmand MR et al (2020) Epidemiology of efflux pumps genes mediating resistance among Staphylococcus aureus; a systematic review. Microb Pathog 139:103850. https://doi.org/10.1016/j.micpath.2019.103850
Jang S (2016) Multidrug efflux pumps in Staphylococcus aureus and their clinical implications. J Microbiol 54:1–8. https://doi.org/10.1007/s12275-016-5159-z
Javadpour MM, Juban MM, Lo W-CJ et al (1996) De novo antimicrobial peptides with low mammalian cell toxicity. J Med Chem 39:3107–3113. https://doi.org/10.1021/jm9509410
Johny AK, Hoagland T, Venkitanarayanan K (2010) Effect of subinhibitory concentrations of plant-derived molecules in increasing the sensitivity of multidrug-resistant Salmonella enterica serovar typhimurium DT104 to antibiotics. Foodborne Pathog Dis 7:1165–1170. https://doi.org/10.1089/fpd.2009.0527
Kaatz GW, Seo SM (2004) Effect of substrate exposure and other growth condition manipulations on norA expression. J Antimicrob Chemother 54:364–369. https://doi.org/10.1093/jac/dkh341
Kachur K, Suntres Z (2020) The antibacterial properties of phenolic isomers, carvacrol and thymol. Crit Rev Food Sci Nutr 60:3042–3053. https://doi.org/10.1080/10408398.2019.1675585
Kapp E, Malan SF, Joubert J, Sampson SL (2017) Small molecule efflux pump inhibitors in Mycobacterium tuberculosis: A rational drug design perspective. Mini-Reviews Med Chem 18:72–86. https://doi.org/10.2174/1389557517666170510105506
Lambert RJW, Skandamis PN, Coote PJ, Nychas G-JE (2001) A study of the minimum inhibitory concentration and mode of action of oregano essential oil, thymol and carvacrol. J Appl Microbiol 91:453–462. https://doi.org/10.1046/j.1365-2672.2001.01428.x
Lamut A, Peterlin Mašič L, Kikelj D, Tomašič T (2019) Efflux pump inhibitors of clinically relevant multidrug resistant bacteria. Med Res Rev 39:2460–2504. https://doi.org/10.1002/med.21591
Lekshmi M, Ammini P, Adjei J et al (2018) Modulation of antimicrobial efflux pumps of the major facilitator superfamily in Staphylococcus aureus. AIMS Microbiol 4:1–18. https://doi.org/10.3934/microbiol.2018.1.1
Liu M, Amini A, Ahmad Z (2017) Safranal and its analogs inhibit Escherichia coli ATP synthase and cell growth. Int J Biol Macromol 95:145–152. https://doi.org/10.1016/j.ijbiomac.2016.11.038
Maia GL de A, Falcão-Silva V dos S, Aquino PGV et al (2011) Flavonoids from Praxelis clematidea R.M. King and Robinson modulate bacterial drug resistance. Molecules 16:4828–4835. https://doi.org/10.3390/molecules16064828
Maisanaba S, Llana-Ruiz-Cabello M, Gutiérrez-Praena D et al (2017) New advances in active packaging incorporated with essential oils or their main components for food preservation. Food Rev Int 33:447–515. https://doi.org/10.1080/87559129.2016.1175010
Miladi H, Zmantar T, Chaabouni Y et al (2016) Antibacterial and efflux pump inhibitors of thymol and carvacrol against food-borne pathogens. Microb Pathog 99:95–100. https://doi.org/10.1016/j.micpath.2016.08.008
Monte DFM, Tavares AG, Albuquerque AR et al (2014) Tolerance response of multidrug-resistant Salmonella enterica strains to habituation to Origanum vulgare L. essential oil. Front Microbiol 5:1–6. https://doi.org/10.3389/fmicb.2014.00721
Oliveira MM, Santos HS, Coutinho HDM et al (2020) Spectroscopic characterization and efflux pump modulation of a thiophene curcumin derivative. J Mol Struct 1215:128291. https://doi.org/10.1016/j.molstruc.2020.128291
Opperman TJ, Nguyen ST (2015) Recent advances toward a molecular mechanism of efflux pump inhibition. Front Microbiol 6:1–16. https://doi.org/10.3389/fmicb.2015.00421
Patil R, Das S, Stanley A et al (2010) Optimized hydrophobic interactions and hydrogen bonding at the target-ligand interface leads the pathways of drug-designing. PLoS ONE 5:e12029. https://doi.org/10.1371/journal.pone.0012029
Peixoto-Neves D, Silva-Alves KS, Gomes MDM et al (2009) Vasorelaxant effects of the monoterpenic phenol isomers, carvacrol and thymol, on rat isolated aorta. Fundam Clin Pharmacol 24:341–350. https://doi.org/10.1111/j.1472-8206.2009.00768.x
Pu Y, Zhao Z, Li Y et al (2016) Enhanced efflux activity facilitates drug tolerance in dormant bacterial cells. Mol Cell 62:284–294. https://doi.org/10.1016/j.molcel.2016.03.035
Quistgaard EM, Löw C, Guettou F, Nordlund P (2016) Understanding transport by the major facilitator superfamily (MFS): structures pave the way. Nat Rev Mol Cell Biol 17:123–132. https://doi.org/10.1038/nrm.2015.25
Rao SP, Dipin KM et al (2018) antimicrobial compounds of plant origin as efflux pump inhibitors: New avenues for controlling multidrug resistant pathogens. J Antimicrob Agents 04:1–6. https://doi.org/10.4172/2472-1212.1000159
Salehzadeh A, Sadat M, Doulabi H et al (2018) The effect of thyme (Thymus vulgaris) extract on the expression of norA efflux pump gene in clinical strains of Staphylococcus aureus. J Genet 4:26–36. https://doi.org/10.22080/jgr.2018.13900.1099
Schindler BD, Kaatz GW (2016) Multidrug efflux pumps of Gram-positive bacteria. Drug Resist Updat 27:1–13. https://doi.org/10.1016/j.drup.2016.04.003
Schindler BD, Frempong-Manso E, DeMarco CE et al (2015) Analyses of multidrug efflux pump-like proteins encoded on the Staphylococcus aureus Chromosome. Antimicrob Agents Chemother 59:747–748. https://doi.org/10.1128/AAC.04678-14
Schmitz D, Shubert VA, Giuliano BM, Schnell M (2014) The broadband microwave spectra of the monoterpenoids thymol and carvacrol: Conformational landscape and internal dynamics. J Chem Phys 141:034304. https://doi.org/10.1063/1.4887337
Schweizer HP (2012) Understanding efflux in Gram-negative bacteria: opportunities for drug discovery. Expert Opin Drug Discov 7:633–642. https://doi.org/10.1517/17460441.2012.688949
Shapira R, Mimran E (2007) Isolation and characterization of Escherichia coli mutants exhibiting altered response to thymol. Microb Drug Resist 13:157–165. https://doi.org/10.1089/mdr.2007.731
Sharom FJ (2008) ABC multidrug transporters: structure, function and role in chemoresistance. Pharmacogenomics 9:105–127. https://doi.org/10.2217/14622416.9.1.105
Silveira Z de S, Macêdo NS, dos Santos JFS et al (2020) Evaluation of the antibacterial activity and efflux pump reversal of thymol and carvacrol against Staphylococcus aureus and their toxicity in Drosophila melanogaster. Molecules 25:2103. https://doi.org/10.3390/molecules25092103
Spengler G, Kincses A, Gajdács M, Amaral L (2017) New roads leading to old destinations: efflux pumps as targets to reverse multidrug resistance in bacteria. Molecules 22:468. https://doi.org/10.3390/molecules22030468
Tegos PG, Haynes M, Jacob Strouse J et al (2011) Microbial efflux pump inhibition: tactics and strategies. Curr Pharm Des 17:1291–1302. https://doi.org/10.2174/138161211795703726
Tintino SR, Oliveira-Tintino CDM, Campina FF et al (2016) Evaluation of the tannic acid inhibitory effect against the NorA efflux pump of Staphylococcus aureus. Microb Pathog 97:9–13. https://doi.org/10.1016/j.micpath.2016.04.003
Trombetta D, Castelli F, Sarpietro MG et al (2005) Mechanisms of antibacterial action of three monoterpenes. Antimicrob Agents Chemother 49:2474–2478. https://doi.org/10.1128/AAC.49.6.2474-2478.2005
Ultee A, Bennik MHJ, Moezelaar R (2002) The phenolic hydroxyl group of carvacrol is essential for action against the food-borne pathogen Bacillus cereus. Appl Environ Microbiol 68:1561–1568. https://doi.org/10.1128/AEM.68.4.1561-1568.2002
Walsh DJ, Livinghouse T, Goeres DM et al (2019) Antimicrobial activity of naturally occurring phenols and derivatives against biofilm and planktonic bacteria. Front Chem 7:1–13. https://doi.org/10.3389/fchem.2019.00653
Youssef D, Molony K (2017) Staphylococcus aureus bacteremia in Adults. In: Frontiers In: Enany S, Alexander LEC (eds), Frontiers in Staphylococcus aureus. IntechOpen, pp 117–131. https://doi.org/10.5772/66225
Acknowledgements
Geopark Araripe; FUNCAP; CAPES.
Funding
This study was funded by the Fundação Cearense de Apoio ao Desenvolvimento Científico e Tecnológico—FUNCAP [BP4-0172-00168.01.00/20]; Coordenação de Aperfeiçoamento de Pessoal de Nível Superior — CAPES.
Author information
Authors and Affiliations
Contributions
Francisco Assis Bezerra da Cunha, Saulo Relison Tintino, Henrique Douglas Melo Coutinho; Conceptualization, Supervision, Coordinated, Cristina Rodrigues dos Santos Barbosa; Investigation, Writing, Original Draft Preparation, Jackelyne Roberta Scherf, Raimundo Luiz Silva Pereira, Joycy Francely Sampaio dos Santos, Sarah Silva Patrício de Jesus, Thais Pereira Lopes, Zildene de Sousa Silveira; Performed the Antibacterial Assays, Irwin Rose Alencar de Menezes; Performed the in Silico Analysis, Thiago Sampaio de Freitas, Cícera Datiane de Morais Oliveira-Tintino; Performed the Statistical Analysis, José Pinto Siqueira Júnior; Contributed With the Resources for the Work.
All authors have read and agreed to the published version of the manuscript.
Corresponding authors
Ethics declarations
Conflict of interest
There was no conflict of interest between authors.
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
dos Santos Barbosa, C.R., Scherf, J.R., de Freitas, T.S. et al. Effect of Carvacrol and Thymol on NorA efflux pump inhibition in multidrug-resistant (MDR) Staphylococcus aureus strains. J Bioenerg Biomembr 53, 489–498 (2021). https://doi.org/10.1007/s10863-021-09906-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10863-021-09906-3